Patients with arthritis have reported being unable to get their methotrexate refills after the Supreme Court decision to strike down Roe v Wade. After the U.S. Supreme court overruled Roe v Wade last ...

Please provide your email address to receive an email when new articles are posted on . Patients with psoriasis taking methotrexate were 2.8 times more likely to develop nonmelanoma skin cancer than ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - The U.S. Food and Drug Administration (FDA) reported on Tuesday Accord Healthcare has resumed manufacturing of ...

(Reuters) - The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to ...

Please provide your email address to receive an email when new articles are posted on . Low-dose methotrexate — the most commonly used drug for systemic rheumatic diseases — was associated with small ...

When Becky Schwarz saw the message in her patient portal saying she could no longer receive a prescription for methotrexate to treat her lupus, she felt surprised. It was only six days after the U.S.

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug ...

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation. The information resource uses recommendation ...

The methotrexate drugs market is driven by rising autoimmune disease prevalence, technological advances in drug delivery, and ...

The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two ...

Nov 7 (Reuters) - The U.S. Food and Drug Administration (FDA) reported on Tuesday Accord Healthcare has resumed manufacturing of methotrexate, one of the most commonly used cancer drugs, amid ongoing ...